| __timestamp | BioCryst Pharmaceuticals, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 33472000 |
| Thursday, January 1, 2015 | 72758000 | 47368000 |
| Friday, January 1, 2016 | 61008000 | 66871000 |
| Sunday, January 1, 2017 | 66962000 | 50675000 |
| Monday, January 1, 2018 | 84888000 | 78821000 |
| Tuesday, January 1, 2019 | 107068000 | 91944000 |
| Wednesday, January 1, 2020 | 122964000 | 111234000 |
| Friday, January 1, 2021 | 208808000 | 207447000 |
| Saturday, January 1, 2022 | 253297000 | 267587000 |
| Sunday, January 1, 2023 | 216566000 | 303055000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, innovation is the key to staying ahead. Over the past decade, BioCryst Pharmaceuticals, Inc. and HUTCHMED (China) Limited have been at the forefront of this race, investing heavily in research and development (R&D). From 2014 to 2023, HUTCHMED has shown a remarkable increase in R&D spending, culminating in a 2023 investment that was approximately 40% higher than BioCryst's. This trend highlights HUTCHMED's commitment to innovation, as their R&D expenses grew from 33 million in 2014 to over 300 million in 2023. Meanwhile, BioCryst also increased its R&D spending significantly, peaking in 2022 with a 390% increase from 2014. These investments underscore the companies' dedication to developing groundbreaking treatments and maintaining a competitive edge in the pharmaceutical industry.
Research and Development Expenses Breakdown: Pfizer Inc. vs HUTCHMED (China) Limited
Analyzing R&D Budgets: Pfizer Inc. vs BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
United Therapeutics Corporation vs HUTCHMED (China) Limited: Strategic Focus on R&D Spending
Dr. Reddy's Laboratories Limited vs HUTCHMED (China) Limited: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
Axsome Therapeutics, Inc. or BioCryst Pharmaceuticals, Inc.: Who Invests More in Innovation?
ADMA Biologics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Bausch Health Companies Inc. vs HUTCHMED (China) Limited
R&D Insights: How HUTCHMED (China) Limited and Mesoblast Limited Allocate Funds
Research and Development Expenses Breakdown: HUTCHMED (China) Limited vs Celldex Therapeutics, Inc.